Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 34, Issue 10, Pages 1077-1090
Publisher
Wiley
Online
2014-08-28
DOI
10.1002/phar.1477
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetic Interaction Study of Ticagrelor and Cyclosporine in Healthy Volunteers
- (2014) Renli Teng et al. CLINICAL DRUG INVESTIGATION
- Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1
- (2014) Duncan Armstrong et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- CYP2C19 Poor Metabolizer Is Associated With Clinical Outcome of Clopidogrel Therapy in Acute Myocardial Infarction But Not Stable Angina
- (2013) Ho-Sook Kim et al. Circulation-Cardiovascular Genetics
- Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients
- (2013) Kathleen Butler et al. CURRENT MEDICAL RESEARCH AND OPINION
- A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers
- (2013) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
- (2013) Ann Wittfeldt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Discharge Aspirin Dose and Clinical Outcomes in Patients With Acute Coronary Syndromes Treated With Prasugrel Versus Clopidogrel
- (2013) Payal Kohli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Variability of on-treatment platelet reactivity in patients on clopidogrel
- (2013) Matthias K. Freynhofer et al. PLATELETS
- Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects
- (2012) Mikko T. Holmberg et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
- (2012) et al. CIRCULATION
- Heart Disease and Stroke Statistics—2013 Update
- (2012) Alan S. Go et al. CIRCULATION
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
- (2012) Patrick T. O’Gara et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Stable Coronary Artery Disease
- (2012) Steen E. Husted et al. CLINICAL PHARMACOKINETICS
- Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals
- (2012) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
- (2012) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects
- (2012) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Safety profile and bleeding risk of ticagrelor compared with clopidogrel
- (2012) Christopher H May et al. Expert Opinion On Drug Safety
- Genetic and non-genetic factors affecting the response to clopidogrel therapy
- (2012) Marta Karaźniewicz-Łada et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy
- (2011) Timothy D. Warner et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
- (2011) Kenneth W. Mahaffey et al. CIRCULATION
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
- (2011) et al. CIRCULATION
- Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes
- (2011) Robert F. Storey et al. EUROPEAN HEART JOURNAL
- Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor
- (2011) Mariano A Giorgi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model
- (2011) J. J. J. van Giezen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC–MS/MS
- (2011) Henrik Sillén et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Pharmacokinetics, Pharmacodynamics, and Safety of Ticagrelor in Volunteers With Severe Renal Impairment
- (2011) Kathleen Butler et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial
- (2011) Benjamin M. Scirica et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
- (2010) Kathleen Butler et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
- (2010) Paul A. Gurbel et al. CIRCULATION
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
- (2010) Philippe Gabriel Steg et al. CIRCULATION
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- In Vitro Evaluation of Potential Drug-Drug Interactions with Ticagrelor: Cytochrome P450 Reaction Phenotyping, Inhibition, Induction, and Differential Kinetics
- (2010) D. Zhou et al. DRUG METABOLISM AND DISPOSITION
- Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
- (2010) R. Teng et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
- (2010) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics, Pharmacodynamics, and Safety of Ticagrelor in Volunteers With Mild Hepatic Impairment
- (2010) Kathleen Butler et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
- (2010) Claes Held et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist
- (2009) Steen Husted et al. Cardiovascular Therapeutics
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
- (2009) Paul P Dobesh PHARMACOTHERAPY
- Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations inP2RY12, P2RY1,andITGB3
- (2009) Robert F. Storey et al. PLATELETS
- Comparison of ticagrelor and thienopyridine P2Y12 binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis
- (2009) J.J.J. van Giezen et al. THROMBOSIS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now